Lead investigator discusses Novavax approval with Orlando TV station

Create a Profile

First Name(Required)

Last Name(Required)

Location Preference(Required)

Phone*(Required)

Email Address*(Required)

Gender

Conditions*(Required)

Race / Ethnicity

Contact Preferences(Required)

I accept digital forms of communication(Required)

I confirm that (1) the name and contact information set forth above is my name and contact information or that I am submitting the form on behalf of an individual who has legally authorized me to submit this request; (2) the personal information I provide in this form may be used by Accel Research Sites, and its affiliates, partners, and medical professionals in connection with considering my potential participation in clinical research studies; (3) I am requesting that Accel Research Sites contact me using the information I have provided on Accel Research Sites’ website; and (4) I have read and understand Accel Research Sites’ Privacy Policy.

CAPTCHA

Hidden

UTM Source

Hidden

UTM Campaign

This field is for validation purposes and should be left unchanged.

Create a Profile

First Name(Required)

Last Name(Required)

Location Preference*(Required)

Phone*(Required)

Email Address*(Required)

Gender

Conditions of Interest*(Required)

Race / Ethnicity

Contact Preferences*(Required)

I accept digital forms of communication(Required)

CAPTCHA

Hidden

UTM Source

Hidden

UTM Campaign

Name

This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

Name(Required)

Last Name(Required)

Phone

Email(Required)

Reason for Contact(Required)

Enter additional message or questions(Required)

I accept digital forms of communication(Required)

I confirm that the name and contact information set forth above is my name and contact information or that I am submitting the form on behalf of an individual who has legally authorized me to submit this request; (2) the personal information I provide in this form may be used by Accel Research Sites, and its affiliates, partners, and medical professionals in connection with considering my potential participation in clinical research studies; (3) I am requesting that Accel Research Sites contact me using the information I have provided on Accel Research Sites’ website; and (4) I have read and understand Accel Research Sites’ Privacy Policy.

CAPTCHA

Name

This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

-- or --

Select City No location found for this Location

FIND A TRIAL NEAR YOU

-- or --

Select City No location found for this Location

Back

Date Published: 07/21/2022

Lead investigator discusses Novavax approval with Orlando TV station

The FDA recently approved the Novavax vaccine for COVID-19.

Dr. Bruce Rankin worked on clinical trials for this vaccine at Accel Research Sites’ DeLand location. He spoke with Orlando’s Fox 35 to share more about what the approval means and the difference between this vaccine and those previously approved.

Watch the segment here.

Back

Articles